These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 3535528)
21. Role of liver transplantation in patients with hepatitis B infection. Holt CD; Millis JM; Busuttil RW Clin Transplant; 1995 Jun; 9(3 Pt 2):269-76. PubMed ID: 7670175 [TBL] [Abstract][Full Text] [Related]
22. Hepatic parenchymal changes and histologic eosinophilia as predictors of subsequent acute liver allograft rejection. Demirhan B; Bilezikçi B; Haberal AN; Sevmiş S; Arat Z; Haberal M Liver Transpl; 2008 Feb; 14(2):214-9. PubMed ID: 18236397 [TBL] [Abstract][Full Text] [Related]
23. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes. Prieto M; Berenguer M; Rayón JM; Córdoba J; Argüello L; Carrasco D; García-Herola A; Olaso V; De Juan M; Gobernado M; Mir J; Berenguer J Hepatology; 1999 Jan; 29(1):250-6. PubMed ID: 9862874 [TBL] [Abstract][Full Text] [Related]
24. Evidence of serious graft damage induced by de novo hepatitis B virus infection after liver transplantation. Segovia R; Sánchez-Fueyo A; Rimola A; Grande L; Bruguera M; Costa J; Soguero C; Uriz J Liver Transpl; 2001 Feb; 7(2):106-12. PubMed ID: 11172393 [TBL] [Abstract][Full Text] [Related]
25. [Viral hepatitis and liver transplantation]. Samuel D; Féray C; Bismuth H Rev Prat; 1995 Jan; 45(2):197-201. PubMed ID: 7725022 [TBL] [Abstract][Full Text] [Related]
26. Liver transplantation for viral hepatitis: the experience of the hepatobiliary center at Hospital Paul Brousse. Samuel D; Feray C; Bismuth H Clin Transpl; 1994; ():157-62. PubMed ID: 7547534 [TBL] [Abstract][Full Text] [Related]
27. Histological and clinical outcome after liver transplantation for hepatitis C. Shuhart MC; Bronner MP; Gretch DR; Thomassen LV; Wartelle CF; Tateyama H; Emerson SS; Perkins JD; Carithers RL Hepatology; 1997 Dec; 26(6):1646-52. PubMed ID: 9398011 [TBL] [Abstract][Full Text] [Related]
29. Donor-specific hyporesponsiveness in ELISPOT assay is associated with early recurrence of hepatitis C in liver transplant recipients. Tambur AR; Ben-Ari Z; Herrera ND; Klein T; Michowiz R; Mor E Hum Immunol; 2005 Jan; 66(1):21-7. PubMed ID: 15620458 [TBL] [Abstract][Full Text] [Related]
30. Hepatitis G virus co-infection does not alter the course of recurrent hepatitis C virus infection in liver transplantation recipients. Cotler SJ; Gretch DR; Bronner MP; Tateyama H; Emond MJ; dela Rosa C; Perkins JD; Carithers RL Hepatology; 1997 Aug; 26(2):432-6. PubMed ID: 9252155 [TBL] [Abstract][Full Text] [Related]
31. Cytokine profile of liver- and blood-derived nonspecific T cells after liver transplantation: T helper cells type 1/0 lymphokines dominate in recurrent hepatitis C virus infection and rejection. Schirren CA; Jung M; Worzfeld T; Mamin M; Baretton GB; Gruener NH; Gerlach JT; Diepolder HM; Zachoval R; Pape GR Liver Transpl; 2000 Mar; 6(2):222-8. PubMed ID: 10719024 [TBL] [Abstract][Full Text] [Related]
32. Chronic hepatitis in patients with active hepatitis B virus and hepatitis C virus combined infections: a histological study. Villari D; Pernice M; Spinella S; Squadrito G; Rodinò G; Brancatelli S; Longo G; Raimondo G Am J Gastroenterol; 1995 Jun; 90(6):955-8. PubMed ID: 7771429 [TBL] [Abstract][Full Text] [Related]
33. Cirrhosis after orthotopic liver transplantation in the absence of primary disease recurrence. Seyam M; Neuberger JM; Gunson BK; Hübscher SG Liver Transpl; 2007 Jul; 13(7):966-74. PubMed ID: 17370332 [TBL] [Abstract][Full Text] [Related]
34. [Treatment of recurrent HCV infection after liver transplantation]. Ostojić R Acta Med Croatica; 2005; 59(5):443-6. PubMed ID: 16381241 [TBL] [Abstract][Full Text] [Related]
35. Change of hepatitis B virus DNA status in anti-HBc positive liver graft. Kwon CH; Suh KS; Cho JY; Yi NJ; Jang JJ; Lee KU Korean J Hepatol; 2006 Jun; 12(2):191-200. PubMed ID: 16804344 [TBL] [Abstract][Full Text] [Related]
36. Factors associated with viral breakthrough in lamivudine monoprophylaxis of hepatitis B virus recurrence after liver transplantation. Chan HL; Chui AK; Lau WY; Chan FK; Wong ML; Tse CH; Rao AR; Wong J; Sung JJ J Med Virol; 2002 Oct; 68(2):182-7. PubMed ID: 12210406 [TBL] [Abstract][Full Text] [Related]
37. The use of hepatitis C viral RNA levels in liver tissue to distinguish rejection from recurrent hepatitis C. Gottschlich MJ; Aardema KL; Burd EM; Nakhleh RE; Brown KA; Abouljoud MS; Hirst K; Moonka DK Liver Transpl; 2001 May; 7(5):436-41. PubMed ID: 11349265 [TBL] [Abstract][Full Text] [Related]
38. [Fulminant and subfulminant hepatitis treated by orthotopic transplantation of the liver. Apropos of 10 cases]. Pouyet M; Ducerf C; Gaussorgues P; Salord F; Sirodot M; Caillon P; Dubois JM; Rivoire M; Baulieux J; Bouletreau P Chirurgie; 1989; 115(8):533-9. PubMed ID: 2700160 [TBL] [Abstract][Full Text] [Related]
39. Recurrent hepatitis C and acute allograft rejection: clinicopathologic features with emphasis on the differential diagnosis between these entities. Moreira RK Adv Anat Pathol; 2011 Sep; 18(5):393-405. PubMed ID: 21841407 [TBL] [Abstract][Full Text] [Related]
40. Intractable recurrent hepatitis A virus infection requiring repeated liver transplantation: a case report. Park GC; Hwang S; Yu YD; Park PJ; Choi YI; Song GW; Jung DH; Ahn CS; Kim KH; Moon DB; Ha TY; Lee SG Transplant Proc; 2010 Dec; 42(10):4658-60. PubMed ID: 21168755 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]